Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Rinse Sampling Method Development – V 2.0

Posted on By

Analytical Method Development: SOP for Rinse Sampling Method Development – V 2.0

Standard Operating Procedure for Development of Rinse Sampling Method for Cleaning Validation


Department Analytical Method Development
SOP No. SOP/AMD/234/2025
Supersedes SOP/AMD/234/2022
Page No. Page 1 of 13
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To establish a validated procedure for developing rinse sampling methods that allow detection and quantification of residual active ingredients, cleaning agents, or microbial contaminants from pharmaceutical manufacturing equipment

surfaces after cleaning operations.

2. Scope

This SOP applies to all rinse sampling method development and validation activities performed by the Analytical Method Development (AMD) department for cleaning validation programs of equipment used in the production of APIs and formulations.

3. Responsibilities

  • Analytical Scientist: Designs rinse sampling procedures and conducts recovery validation and detection limit assessment.
  • QC Analyst: Performs replicate testing and supports in ruggedness and precision studies.
  • QA Executive: Reviews and approves the rinse sampling method validation protocol and final report.
See also  Analytical Method Development: SOP for Homogeneity Test of Topical Preparations - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the development, validation, and implementation of scientifically justified and GMP-compliant rinse sampling methods.

5. Procedure

5.1 Selection of Rinse Solvent

  1. Select solvent based on solubility of target analyte and material compatibility (e.g., WFI, acetonitrile, dilute NaOH).
  2. Use highest grade solvents to minimize background contamination.

5.2 Preparation of Spiked Surfaces

  1. Spike known amount of analyte onto representative surfaces (e.g., SS-316, glass, PTFE).
  2. Allow to dry completely under controlled conditions before rinsing.

5.3 Rinse Sampling Procedure

  1. Rinse surface with a fixed volume of solvent (e.g., 100 mL per 1000 cm²).
  2. Collect rinse into sterile or clean collection container.
  3. Agitate and transfer to appropriate container for analysis.

5.4 Analytical Method Selection

  1. Use HPLC, TOC, UV spectrophotometry, or conductivity based on analyte type.
  2. Use validated methods for quantification and sensitivity.
See also  Analytical Method Development: SOP for Use of Reference Standards - V 2.0

5.5 Recovery Study and Validation

  1. Calculate percent recovery using:

    % Recovery = (Amount Recovered / Amount Spiked) × 100
  2. Acceptable recovery:
    • ≥80% for API and cleaning agents
    • ≥50% for microbial rinses
  3. Perform replicate testing (n=3) to assess repeatability and precision.

5.6 Documentation

  1. Record all details including spiking concentration, rinse volume, surface area, analysis results, and calculations in Annexures.
  2. Prepare a rinse method validation report and submit to QA.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • TOC: Total Organic Carbon
  • HPLC: High Performance Liquid Chromatography
  • API: Active Pharmaceutical Ingredient
  • QA: Quality Assurance

7. Documents

  1. Rinse Sampling Recovery Log – Annexure-1
  2. Rinse Volume and Surface Mapping Record – Annexure-2
  3. Rinse Sampling Method Validation Report – Annexure-3

8. References

  • FDA Guidance for Industry: Cleaning Validation
  • ICH Q7: GMP for Active Pharmaceutical Ingredients
  • WHO TRS 1019 Annex 3: Points to Consider in Cleaning Validation

9. SOP Version

Version: 2.0

See also  Analytical Method Development: Selection of Mobile Phase for Chromatographic Techniques - V 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Kavita Joshi Manoj Desai Sunita Reddy
Designation Analytical Scientist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Rinse Sampling Recovery Log

Analyte Surface Spiked Amount (µg) Recovered (µg) Recovery (%) Status
Ibuprofen SS-316 100 88 88% Pass

Annexure-2: Rinse Volume and Surface Mapping

Equipment Surface Area (cm²) Rinse Volume (mL) Rinse Solvent
Fluid Bed Dryer 2500 250 WFI

Annexure-3: Rinse Sampling Method Validation Report

Rinse sampling method validated for Ibuprofen using WFI as rinse solvent. Method shows recovery of 88% with RSD of 5.1%. All validation parameters within acceptable range. Method approved for routine cleaning validation studies.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included microbial rinse validation option and updated annexures Annual SOP Review Sunita Reddy
08/05/2022 1.0 Initial SOP Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Labeling and Coding of Gel Products Before Secondary Packing – V 2.0
Next Post: SOP Training for New Joinees: Where to Start

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version